Prolonged Calcitonin Receptor Signaling by Salmon, but Not Human Calcitonin, Reveals Ligand Bias
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Salmon calcitonin (sCT) and human calcitonin (hCT) are pharmacologically distinct. However, the reason for the differences is unclear. Here we analyze the differences between sCT and hCT on the human calcitonin receptor (CT(a)R) with respect to activation of cAMP signaling, β-arrestin recruitment, ligand binding kinetics and internalization. The study was conducted using mammalian cell lines heterologously expressing the human CT(a) receptor. CT(a)R downstream signaling was investigated with dose response profiles for cAMP production and β-arrestin recruitment for sCT and hCT during short term (<2 hours) and prolonged (up to 72 hours) stimulation. CT(a)R kinetics and internalization was investigated with radio-labeled sCT and hCT ligands on cultured cells and isolated membrane preparations from the same cell line. We found that sCT and hCT are equipotent during short-term stimulations with differences manifesting themselves only during long-term stimulation with sCT inducing a prolonged activation up to 72 hours, while hCT loses activity markedly earlier. The prolonged sCT stimulation of both cAMP accumulation and β-arrestin recruitment was attenuated, but not abrogated by acid wash, suggesting a role for sCT activated internalized receptors. We have demonstrated a novel phenomenon, namely that two distinct CT(a)R downstream signaling activation patterns are activated by two related ligands, thereby highlighting qualitatively different signaling responses in vitro that could have implications for sCT use in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recently, studies that compared the binding of sCT and hCT to the CTR have found that the different ligands not only affect receptor conformation, but also modulate the bound G protein and the kinetics of downstream signaling (9,75).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A recent study demonstrated that these ligands are equipotent during short-term stimulation.However, long-term stimulation with sCT results in sustained activation of CTR, whereas hCT loses its activity much earlier (9).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Poyner, D. R., Sexton, P. M., Marshall, I., Smith, D. M., Quirion, R., Born, W., Muff, R., Fischer, J. A., & Foord, S. M. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.233 · Cited by 804 · cited 4×
“The CT(a) and CT(b) receptors are the two major alternatively spliced isoforms expressed in humans and have different properties with respect to activation of downstream signaling pathways for each isoform and in their tissue distribution, with the CT(a) receptor being the most abundant [3,4].”
BackgroundResultInfluentialSelf-citationβ-arrestin-mediated receptor trafficking and signal transduction
Shenoy, S. K., & Lefkowitz, R. J. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.05.002 · Cited by 712
Sustained cyclic AMP production by parathyroid hormone receptor endocytosis
Ferrandon, S., Feinstein, T. N., Castro, M., Wang, B., Bouley, R., Potts, J. T., Gardella, T. J., & Vilardaga, J.-P. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.206 · Cited by 572
Degorce, F. (2009) · Current Chemical Genomics · doi:10.2174/1875397300903010022 · Cited by 501 · cited 1×
“Quantification of the intracellular cAMP was measured directly in the wells using the cAMP FEMTO TB KIT [23] (62AM7PEB, Cisbio Bioassays) according to the manufacturer’s instructions.”
MethodHobbs, S., Jitrapakdee, S., & Wallace, J. C. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9646 · Cited by 254
Fischer, J. A., Tobler, P. H., Kaufmann, M., Born, W., Henke, H., Cooper, P. E., Sagar, S. M., & Martin, J. B. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.12.7801 · Cited by 201
The structure and mechanism of formation of human calcitonin fibrils.
Arvinte, T., Cudd, A., & Drake, A. F. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53268-3 · Cited by 172
Sexton, P. M., Findlay, D. M., & Martin, T. J. (1999) · Current Medicinal Chemistry · doi:10.2174/092986730611220401164504 · Cited by 163
Self-citationForty years of calcitonin—where are we now? A tribute to the work of Iain Macintyre, FRS
Zaidi, M., Inzerillo, A. M., Moonga, B. S., Bevis, P. J. R., & Huang, C. L.-H. (2002) · Bone · doi:10.1016/s8756-3282(02)00688-9 · Cited by 151 · cited 1×
“In general, any increased homology with sCT increases the biological activity of the agonists [10].”
BackgroundCloning and characterization of an abundant subtype of the human calcitonin receptor.
Kuestner, R. E., Elrod, R. D., Grant, F. J., Hagen, F. S., Kuijper, J. L., Matthewes, S. L., O'Hara, P. J., Sheppard, P. O., Stroop, S. D., & Thompson, D. L. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09678-6 · Cited by 149
Research works printed but not linked: 1
- 1. Azria M (1989) The calcitonins. Karger.
Cited by
Biased signalling: from simple switches to allosteric microprocessors
Smith, J. S., Lefkowitz, R. J., & Rajagopal, S. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.229 · Cited by 738
Amylin: Pharmacology, Physiology, and Clinical Potential
Hay, D. L., Chen, S., Lutz, T. A., Parkes, D. G., & Roth, J. D. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010629 · Cited by 400
“There has been no specific investigation of whether amylin-induced ERK activation is G protein dependent or arrestin mediated; however, the calcitonin receptor can recruit arrestin in response to human and salmon calcitonin (Andreassen et al., 2014).”
BackgroundUpdate on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25
Hay, D. L., Garelja, M. L., Poyner, D. R., & Walker, C. S. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14075 · Cited by 370
The role of kinetic context in apparent biased agonism at GPCRs
Klein Herenbrink, C., Sykes, D. A., Donthamsetti, P., Canals, M., Coudrat, T., Shonberg, J., Scammells, P. J., Capuano, B., Sexton, P. M., Charlton, S. J., et al. (2016) · Nature Communications · doi:10.1038/ncomms10842 · Cited by 328
Self-citationPTH receptor-1 signalling—mechanistic insights and therapeutic prospects
Cheloha, R. W., Gellman, S. H., Vilardaga, J.-P., & Gardella, T. J. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.139 · Cited by 265
A kinetic view of GPCR allostery and biased agonism
Lane, J. R., May, L. T., Parton, R. G., Sexton, P. M., & Christopoulos, A. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2431 · Cited by 166
Self-citationToo Much of a Good Thing? On the Relationship Between CSR and Employee Work Addiction
Brieger, S. A., Anderer, S., Fröhlich, A., Bäro, A., & Meynhardt, T. (2019) · Journal of Business Ethics · doi:10.1007/s10551-019-04141-8 · Cited by 153
The Activity of Peptides of the Calcitonin Family in Bone
Naot, D., Musson, D. S., & Cornish, J. (2019) · Physiological Reviews · doi:10.1152/physrev.00066.2017 · Cited by 141
Ligand-Dependent Modulation of G Protein Conformation Alters Drug Efficacy
Furness, S. G. B., Liang, Y.-L., Nowell, C. J., Halls, M. L., Wookey, P. J., Dal Maso, E., Inoue, A., Christopoulos, A., Wootten, D., & Sexton, P. M. (2016) · Cell · doi:10.1016/j.cell.2016.09.021 · Cited by 134
Self-citationWorkaholism and work–family conflict among university academics
Torp, S., Lysfjord, L., & Midje, H. H. (2018) · Higher Education · doi:10.1007/s10734-018-0247-0 · Cited by 138
Paracrine signalling by cardiac calcitonin controls atrial fibrogenesis and arrhythmia
Moreira, L. M., Takawale, A. R., Hulsurkar, M. M., Menassa, D. A., Antanaviciute, A., Lahiri, S. K., Mehta, N., Evans, N., Psarros, C., Robinson, P. J., et al. (2020) · Nature · doi:10.1038/s41586-020-2890-8 · Cited by 120
Allostery and biased agonism at class B G protein-coupled receptors
Wootten, D., Miller, L. J., Koole, C., Christopoulos, A., & Sexton, P. M. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00049 · Cited by 112
Self-citationStructural insights into emergent signaling modes of G protein–coupled receptors
Sutkevičiu̅tė, I., & Vilardaga, J. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.009348 · Cited by 120
Drug delivery systems functionalized with bone mineral seeking agents for bone targeted therapeutics
Rotman, S. G., Grijpma, D. W., Richards, R. G., Moriarty, T. F., Eglin, D., & Guillaume, O. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.009 · Cited by 110
Fluorescent ligands: Bringing light to emerging GPCR paradigms
Soave, M., Briddon, S. J., Hill, S. J., & Stoddart, L. A. (2020) · British Journal of Pharmacology · doi:10.1111/bph.14953 · Cited by 97
Amylin and Calcitonin: Potential Therapeutic Strategies to Reduce Body Weight and Liver Fat
Mathiesen, D. S., Lund, A., Vilsbøll, T., Knop, F. K., & Bagger, J. I. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.617400 · Cited by 86
Calcitonin and Bone Physiology: In Vitro, In Vivo, and Clinical Investigations
Xie, J., Guo, J., Kanwal, Z., Wu, M., Lv, X., Ibrahim, N. A., Li, P., Buabeid, M. A., Arafa, E. A., & Sun, Q. (2020) · International Journal of Endocrinology · doi:10.1155/2020/3236828 · Cited by 83
New Insights into the Structure and Function of Class B1 GPCRs
Cary, B. P., Zhang, X., Cao, J., Johnson, R. M., Piper, S. J., Gerrard, E. J., Wootten, D. L., & Sexton, P. M. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac033 · Cited by 77
Self-citationFletcher, M. M., Keov, P., Truong, T. T., Mennen, G., Hick, C. A., Zhao, P., Furness, S. G. B., Kruse, T., Clausen, T. R., Wootten, D., et al. (2021) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.121.000567 · Cited by 68
Self-citationCan residence time offer a useful strategy to target agonist drugs for sustained GPCR responses?
Hothersall, J. D., Brown, A. J., Dale, I., & Rawlins, P. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2015.07.015 · Cited by 70
Lessons learned from the clinical development of oral peptides
Karsdal, M. A., Riis, B. J., Mehta, N., Stern, W., Arbit, E., Christiansen, C., & Henriksen, K. (2015) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12557 · Cited by 63
Self-citationBeyond CGRP: The calcitonin peptide family as targets for migraine and pain
Rees, T. A., Hendrikse, E. R., Hay, D. L., & Walker, C. S. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15605 · Cited by 69
Sonne, N., Karsdal, M. A., & Henriksen, K. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101109 · Cited by 63
Self-citationGydesen, S., Andreassen, K. V., Hjuler, S. T., Christensen, J. M., Karsdal, M. A., & Henriksen, K. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00514.2015 · Cited by 57
Self-citationG Protein–Coupled Receptor Signaling: New Insights Define Cellular Nanodomains
Lohse, M. J., Böck, A., & Zaccolo, M. (2023) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-040623-115054 · Cited by 63
New Insights into the Regulation of CGRP-Family Receptors
Gingell, J. J., Hendrikse, E. R., & Hay, D. L. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.11.005 · Cited by 54
da Silva, A. M. B., Silva-Gonçalves, L. C., Oliveira, F. A., & Arcísio-Miranda, M. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0782-1 · Cited by 56
Peptides in the regulation of glucagon secretion
Andersen, D. B., & Holst, J. J. (2022) · Peptides · doi:10.1016/j.peptides.2021.170683 · Cited by 43
The Molecular Control of Calcitonin Receptor Signaling
Maso, E. D., Glukhova, A., Zhu, Y., García‐Nafría, J., Tate, C. G., Atanasio, S., Reynolds, C. A., Ramírez-Aportela, E., Carazo, J. M., Hick, C. A., et al. (2019) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.8b00056 · Cited by 48
Self-citationLarsen, A. T., Mohamed, K. E., Sonne, N., BREDTOFT, E.-M., Andersen, F., Karsdal, M. A., & Henriksen, K. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113842 · Cited by 43
Self-citationAndreassen, K. V., Larsen, A. T., Sonne, N., Mohamed, K. E., Karsdal, M. A., & Henriksen, K. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101282 · Cited by 39
Self-citationLarsen, A. T., Sonne, N., Andreassen, K. V., Karsdal, M. A., & Henriksen, K. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.263392 · Cited by 35
Self-citationLarsen, A. T., Sonne, N., Andreassen, K. V., Gehring, K., Karsdal, M. A., & Henriksen, K. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.257576 · Cited by 34
Self-citationGydesen, S., Andreassen, K. V., Hjuler, S. T., Hellgren, L. I., Karsdal, M. A., & Henriksen, K. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00419.2016 · Cited by 34
Self-citationMaso, E. D., Zhu, Y., Pham, V., Reynolds, C. A., Deganutti, G., Hick, C. A., Yang, D., Christopoulos, A., Hay, D. L., Wang, M.-W., et al. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.02.005 · Cited by 30
Self-citationMaso, E. D., Just, R., Hick, C. A., Christopoulos, A., Sexton, P. M., Wootten, D. L., & Furness, S. G. B. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.12.016 · Cited by 29
Self-citationCagrilintide lowers bodyweight through brain amylin receptors 1 and 3
Carvas, A. O., Leuthardt, A. S., Kulka, P., Lommi, G., Hassan, S., Coester, B., Lundh, S. H., Pers, T. H., Secher, A. L., Raun, K., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105836 · Cited by 29
Hothersall, J. D., Guo, D. M., Sarda, S., Sheppard, R. J., Chen, H., Keur, W., Waring, M. J., IJzerman, A. P., Hill, S. J., Dale, I. L., et al. (2016) · Molecular Pharmacology · doi:10.1124/mol.116.105551 · Cited by 26
Katri, A., Dąbrowska, A., Löfvall, H., Karsdal, M. A., Andreassen, K. V., Thudium, C. S., & Henriksen, K. (2019) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2019.05.016 · Cited by 28
Self-citationFresh-blood-free diet for rearing malaria mosquito vectors
Marques, J., Cardoso, J. C. R., Félix, R. C., Santana, R. A. G., Guerra, M. D. G. V. B., Power, D. M., & Silveira, H. (2018) · Scientific Reports · doi:10.1038/s41598-018-35886-3 · Cited by 23
Bone-seeking agents for the treatment of bone disorders
Cawthray, J. F., Wasan, E. K., & Wasan, K. M. (2017) · Drug Delivery and Translational Research · doi:10.1007/s13346-017-0394-3 · Cited by 23
Sustained wash-resistant receptor activation responses of GPR119 agonists
Hothersall, J. D., Bussey, C. E., Brown, A., Scott, J. S., Dale, I. L., & Rawlins, P. B. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.06.031 · Cited by 23
Ostrovskaya, A., Hick, C. A., Hutchinson, D. S., Stringer, B. W., Wookey, P. J., Wootten, D. L., Sexton, P. M., & Furness, S. G. B. (2019) · BMC Cancer · doi:10.1186/s12885-019-5369-y · Cited by 25
Self-citationTHERAPY OF ENDOCRINE DISEASE: Amylin and calcitonin – physiology and pharmacology
Mathiesen, D. S., Lund, A., Holst, J. J., Knop, F. K., Lutz, T. A., & Bagger, J. I. (2022) · European Journal of Endocrinology · doi:10.1530/eje-21-1261 · Cited by 23
In vitro anti-HIV and antioxidant potential of Bulbine frutescens (Asphodelaceae)
Shikalepo, R., Mukakalisa, C., Kandawa‐Schulz, M., Chingwaru, W., & Kapewangolo, P. T. (2017) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2017.09.007 · Cited by 21
Đorđević, N. O., Pejin, B., Novaković, M., Stanković, D. M., Mutić, J. J., Pajović, S. B., & Tešević, V. (2017) · Scientia Horticulturae · doi:10.1016/j.scienta.2017.07.045 · Cited by 19
Boccia, L., Borner, T., Ghidewon, M. Y., Kulka, P., Piffaretti, C., Doebley, S. A., Jonghe, B. C. D., Grill, H. J., Lutz, T. A., & Foll, C. L. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101444 · Cited by 18
Safety, tolerability and pharmacokinetic characterisation of DACRA KBP‐042 in healthy male subjects
Henriksen, K., Broekhuizen, K., de Boon, W. M. I., Karsdal, M. A., Bihlet, A. R., Christiansen, C., Dillingh, M. R., de Kam, M., Kumar, R., Burggraaf, J., et al. (2021) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14921 · Cited by 19
Self-citationSonne, N., Larsen, A. T., Andreassen, K. V., Karsdal, M. A., & Henriksen, K. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.263723 · Cited by 17
Self-citationBiased Profile of Xanomeline at the Recombinant Human M4 Muscarinic Acetylcholine Receptor
McDonald, J. K., van der Westhuizen, E. T., Pham, V., Thompson, G. V., Felder, C. C., Paul, S. M., Thal, D. M., Christopoulos, A., & Valant, C. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00827 · Cited by 17
Self-citationLarsen, A. T., Sonne, N., Andreassen, K. V., Karsdal, M. A., & Henriksen, K. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.263400 · Cited by 17
Self-citationThe new fate of internalized membrane receptors: Internalized activation
Wang, W., Bian, J., Sun, Y., & Li, Z. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108018 · Cited by 17
An insight into chemical composition and biological activity of Montenegrin Vranac red wine
Đorđević, N. O., Novaković, M., Pejin, B., Živković, M., Savic, A. G., Mutić, J. J., & Tešević, V. (2017) · Scientia Horticulturae · doi:10.1016/j.scienta.2017.11.033 · Cited by 16
Cary, B. P., Hager, M. V., Mariam, Z., Morris, R. K., Belousoff, M. J., Deganutti, G., Sexton, P. M., Wootten, D. L., & Gellman, S. H. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2407574122 · Cited by 13
Self-citationPatient Survival and Length of Stay Associated With Delayed Rapid Response System Activation
Padilla, R. M., & Mayo, A. M. (2019) · Critical Care Nursing Quarterly · doi:10.1097/cnq.0000000000000264 · Cited by 12
When studying becomes an obsession: The Studyholism Inventory – Extended Version (SI-15)
Loscalzo, Y., & Giannini, M. (2020) · Current Psychology · doi:10.1007/s12144-020-01168-3 · Cited by 14
Salmon Calcitonin Exerts an Antidepressant Effect by Activating Amylin Receptors
Jiang, J. W., Ju, J., Luo, L., Song, Z., Liao, H., Yang, X., Wei, S., Wang, D., Wenhui, Z., Chang, J., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.826055 · Cited by 14
Giansanti, M., Gabrieli, A. D., Prete, S. P., Ottone, T., Divona, M. D., Karimi, T., Ciccarone, F., Voso, M. T., Graziani, G., & Faraoni, I. (2021) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.121.000537 · Cited by 13
Sonne, N., Larsen, A. T., Karsdal, M. A., & Henriksen, K. (2022) · Biomedicines · doi:10.3390/biomedicines10102365 · Cited by 11
Self-citationZeeman, Z., Branch, G. M., Pillay, D., & von der Heyden, S. (2020) · Biological Invasions · doi:10.1007/s10530-020-02257-x · Cited by 11
Taşkıran, A. Ş., & Ergül, M. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00793-6 · Cited by 12
Yuliantie, E., van der Velden, W. J. C., Labroska, V., Dai, A., Zhao, F., Darbalaei, S., Deganutti, G., Xu, T., Zhou, Q., Yang, D., et al. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114715 · Cited by 10
Self-citationReceptors for parathyroid hormone and parathyroid hormone–related protein
Gardella, T. J., Jüppner, H., & Potts, J. T. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00028-2 · Cited by 10
Amylin receptor subunit interactions are modulated by agonists and determine signaling
Gostynska, S. E., Karim, J. A., Ford, B. E., Gordon, P. H., Babin, K. M., Inoue, A., Lambert, N. A., & Pioszak, A. A. (2025) · Science Signaling · doi:10.1126/scisignal.adt8127 · Cited by 11
Roberts, B., Mattei, A. E., Howard, K. E., Weaver, J. L., Liu, H., Lélias, S., Martin, W. D., Verthelyi, D. I., Pang, E. S., Edwards, K. J., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1363139 · Cited by 9
Hibbins, A. R., Govender, M., Indermun, S., Kumar, P., du Toit, L. C., Choonara, Y. E., & Pillay, V. (2018) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2018.02.004 · Cited by 9
Receptor dimers and biased ligands: Novel strategies for targeting G protein-coupled receptors
Liu, W., Wang, D., Wang, L., Hu, S., Jiang, Y., Wang, Y., Cai, X., & Chen, J. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108829 · Cited by 6
Babin, K. M., Kılınç, C., Gostynska, S. E., Dickson, A., & Pioszak, A. A. (2025) · Biochemistry · doi:10.1021/acs.biochem.4c00812 · Cited by 5
Melander, S. A., Larsen, A. T., Karsdal, M. A., & Henriksen, K. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16329 · Cited by 6
Self-citationSalmon calcitonin: conformational changes and stabilizer effects
Lin, S. (2015) · AIMS Biophysics · doi:10.3934/biophy.2015.4.695 · Cited by 8
Where are we now? Biased signalling of Class B G protein-coupled receptor-targeted therapeutics
Tasma, Z., Garelja, M. L., Jamaluddin, A., Alexander, T. I., & Rees, T. A. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108846 · Cited by 4
Calcitonin: Survey of new anatomy data to pathology and therapeutic aspects
Faour, O., & Gilloteaux, J. (2017) · Translational Research in Anatomy · doi:10.1016/j.tria.2017.01.001 · Cited by 7
Smith, A. A., Thomas, J., Friedhoff, C., & Chin, E. (2021) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acab065 · Cited by 4
Involvement of nitric oxide pathway in the acute anticonvulsant effect of salmon calcitonin in rats
Filiz, A. K., & Karabulut, S. (2022) · Epilepsy Research · doi:10.1016/j.eplepsyres.2022.106864 · Cited by 5
Vilardaga, J., Saha, S., Lee, J. Y., Clark, L. J., & Bahar, İ. (2025) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2025.103170 · Cited by 3
Cong, X., Liu, H., Liu, L., Castelán, N. E., Jones, K. G. E., Egertová, M., Elphick, M. R., & Chen, M. (2025) · eLife · doi:10.7554/elife.101799 · Cited by 3
Modulation of amylin and calcitonin receptor activation by hybrid peptides
Lee, S. M. (2024) · Peptides · doi:10.1016/j.peptides.2024.171314 · Cited by 3
Kinetics of ligand binding and signaling
Gherbi, K., Groenewoud, N. J., Holliday, N. D., Sengmany, K., & Charlton, S. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816228-6.00010-6 · Cited by 5
Unraveling the aggregation mechanism and bioactivity of Tyr12 nitrated human calcitonin
Hu, T., Wei, Y., Wei, J., Wang, M., Fu, S., Gao, Z., & Li, H. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.144577 · Cited by 3
Amylin and amylin receptors in Alzheimer's disease
Fu, W., & Jhamandas, J. H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815868-5.00020-7 · Cited by 1
Katri, A., Reker, D., Karsdal, M. A., Bay‐Jensen, A., & Henriksen, K. (2021) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001722 · Cited by 1
Self-citationCong, X., Liu, H., Liu, L., Elphick, M. R., & Chen, M. (2024) · eLife · doi:10.7554/elife.101799.1 · Cited by 1
Bockaert, J. (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732397724.793585445
Cong, X., Liu, H., Liu, L., Egertová, M., Elphick, M. R., & Chen, M. (2025) · eLife · doi:10.7554/elife.101799.2
Structure-Encoded Location Biased Signaling in a Class B GPCR: Focus on the PTH Type 1 Receptor
Pena, K. A., & Vilardaga, J. (2025) · Handbook of experimental pharmacology · doi:10.1007/164_2025_763
Cong, X., Liu, H., Liu, L., Castelán, N. E., Jones, K. G., Egertová, M., Elphick, M. R., & Chen, M. (2025) · eLife · doi:10.7554/elife.101799.3
What we can learn from fish calcitonin and its receptor: evolutionary insights and medical potential
Yang, Y.-Y., & Liu, J. (2025) · LabMed discovery. · doi:10.1016/j.lmd.2025.100108
Dual amylin and calcitonin receptor agonists as multifaceted disease-modifying osteoarthritis drugs
Mohamed, K., Larsen, A. T., Thudium, C. S., Bezerra, A. B. G., Karsdal, M. A., Bay‐Jensen, A., & Henriksen, K. (2026) · International Journal of Obesity · doi:10.1038/s41366-026-02124-0
Self-citation
Metadata
- Authors
- Andreassen, K. V., Hjuler, S. T., Furness, S. G., Sexton, P. M., Christopoulos, A., Nosjean, O., Karsdal, M. A., & Henriksen, K.
- Affiliations
- Nordic Bioscience (Denmark) (DK)
- Monash University (AU)
- Servier (France) (FR)
- Corresponding author
- Andreassen, Kim Vietz
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-03-18
- Volume
- 9
- Issue
- 3
- Pages
- e92042
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3958426
- OpenAlex
- W1986267285
- Cited by
- 89
- References
- 36
- Citations by year
- 2026: 1 · 2025: 12 · 2024: 5 · 2023: 1 · 2022: 8 · 2021: 13 · 2020: 11 · 2019: 9 · 2018: 7 · 2017: 11 · 2016: 5 · 2015: 5 · 2014: 1
- FWCI
- 3.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Monash University Research Portal (Monash University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Keywords
- salmon calcitonin, human calcitonin, calcitonin receptor, ligand bias, receptor internalization, cAMP signaling, β-arrestin recruitment, receptor desensitization, acid washing
- MeSH terms
- beta-Arrestins, Cyclic AMP, Animals, Calcitonin, Cell Line, Gene Expression Regulation, Humans, Ligands, Salmon, Species Specificity, Time Factors, Signal Transduction, Receptors, Calcitonin, Transgenes, Arrestins, Protein Transport
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.